SEC Form 4 · accession 0001102624-15-000356
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Mar 9, 2015
Accepted (ET)
Mar 10, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2015 | P | 3,000 | $0.205 | A | 7,548,985 | D | |
| Common Stock | Mar 9, 2015 | P | 3,000 | $0.21 | A | 7,551,985 | D | |
| Common Stock | Mar 9, 2015 | P | 2,285 | $0.23 | A | 7,554,270 | D | |
| Common Stock | Mar 9, 2015 | P | 465 | $0.24 | A | 7,554,735 | D | |
| Common Stock | Mar 9, 2015 | P | 1,250 | $0.245 | A | 7,555,985 | D |
Table II — derivative securities
No Table II lines on this filing.